Blood Pressure Management for Weight-Concerned Patients

First-Line Therapy Options

The American College of Cardiology recommends ACE inhibitors, ARBs, or calcium channel blockers as first-line therapy for patients with hypertension who are concerned about weight gain, due to their weight-neutral effects 1
ACE inhibitors and ARBs are recommended as first-line therapy for hypertension, with demonstrated cardiovascular protection and reduction in CVD events by 20-30% with a 10 mm Hg systolic BP reduction 2
Calcium channel blockers, such as amlodipine, are weight-neutral and appropriate as first-line therapy, particularly when added to ACE inhibitors or ARBs 1, 2

Beta-blockers should be avoided as first-line antihypertensive treatment in patients with overweight or obesity, due to adverse metabolic effects including weight gain, negative effects on lipids, and insulin resistance 1, 3
Thiazide diuretics should be avoided in weight-concerned patients due to dose-related side effects including dyslipidemia and insulin resistance 1, 2

The American Heart Association recommends starting with an ACE inhibitor or ARB as first-line therapy, with alternative options including calcium channel blockers if ACE inhibitor/ARB is contraindicated 1, 2
If blood pressure is not controlled, adding a calcium channel blocker to the ACE inhibitor/ARB is recommended, while avoiding beta-blockers or thiazide diuretics if weight is a concern 1, 2

The American College of Cardiology advises against combining ACE inhibitors with ARBs or with direct renin inhibitors, due to lack of added cardiovascular benefit and increased adverse events 2
Lifestyle modifications, including weight loss, sodium restriction, and physical activity, should be initiated alongside pharmacologic therapy 2